Impact of Blood Vessel Implantation on Quality of Life With Cancer Patients: A Focused Analysis

Background: Breast cancer patients often undergo artificial vascular implantation for long‐term intravenous therapies, which can significantly impact their quality of life (QoL). While vascular access is critical for treatment, the relationship between artificial vascular implantation and QoL outcomes remains underexplored. Understanding the factors influencing QoL after implantation, such as patient demographics, disease characteristics, and treatment protocols, is essential for optimizing patient care and improving recovery. Objectives: This research investigated the impact of artificial vascular implantation on the QoL in patients with breast cancer. Sample and Setting: A case‐control study design was utilized in this research. Data collection was conducted from January 1, 2023, to June 31, 2023, encompassing 120 patients diagnosed with breast cancer who had undergone artificial vascular implantation within the previous three years of Zuoying Armed Forces General Hospital in Taiwan. Methods: Data acquisition was executed via questionnaires, followed by analysis employing descriptive statistics and multivariate regression to facilitate inferential statistical assessments. Results: Breast cancer patients with hypertension ( β = −0.612) have a lower QoL after artificial in breast cancer patients after artificial vascular implantation. Conclusions: This research underscores the potential advantages of artificial blood vessel implantation, not only in terms of medical outcomes but also in enhancing patients’ daily lives. However, breast cancer patients with hypertension experience a lower QoL after the procedure. Future studies should address the current limitations and further investigate the long‐term effects of this procedure on cancer survivors, with the goal of improving their treatment experiences and overall well‐being.